Consumer Defensive
Live Price
Offline$4.39
+0.00% today
1Y Change
-45.80%
Window
Jun 25, 2025 โ Jun 23, 2026
Coverage: 257 bars ยท Jun 25, 2025 โ Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
China Feihe Ltd (CFEIY) is a Consumer Defensive stock with a market cap of $27.26B and listed on OTC. The stock last traded around $4.39 and down 45.8% across the available one-year price window (Jun 25, 2025 โ Jun 23, 2026). Baseline metrics include revenue growth of -15.1%, EPS growth of -46.2%, a dividend yield of 8.2%. What stands out right now is revenue -15.1%, EPS -46.2%, free cash flow -76.0% with operating margin 16.2% and ROIC 6.5%. The dividend matters to the case here, with a current yield around 8.2%. Valuation is more restrained than many high-expectation growth names at P/E 14.1 and price/sales 1.5. Overall, the current profile looks closer to a income-oriented value setup than a generic broad-market placeholder. Stock Foundry combines CFEIY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-15.1% vs +1.7% peer median
Operating Margin
Above sector median
+16.2% vs +6.6% peer median
P/E
Near sector median
14.1 vs 14.0 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Mar 28, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -15.1% and EPS is at -46.2%, with operating margin around 16.2%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 8.2%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -0.6% over the next 5 trading days and finished higher after 0 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Mar 28, 2026 | โ | +0.0% | +0.0% | -9.8% |
2025 Sep 4, 2025 | โ | +0.0% | -1.9% | -17.2% |
2024 Dec 31, 2024 | โ | +0.0% | +0.0% | -27.0% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CFEIY
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CFEIY Max Drawdown
-45.83%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for CFEIY and SPY.
Company Overview
China Feihe Ltd
OTC
China Feihe Ltd is a prominent player in the dairy products industry, specializing in the production and distribution of high-quality infant formula and nutritional products. It primarily operates in China, where it holds a significant market share, catering to the country's increasing demand for reliable and nutritious infant foods. Known for its comprehensive range of product offerings, China Feihe Ltd provides various formulas designed to support infant growth and development during their crucial early years. The company's products are characterized by rigorous quality control and innovative research and development processes, ensuring they meet and exceed customer expectations. With a robust distribution network encompassing rural and urban areas, China Feihe Ltd plays an essential role in addressing nutritional needs across demographics. As a key participant in China's consumer goods sector, the company contributes significantly to the economic fabric of the nation and continues to expand its influence in the growing infant nutrition market.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.